P. Gaszner

发表

The development of a short form of the EMBU : Its appraisal with students in Greece, Guatemala, Hungary and Italy

M. Eisemann, W. Arrindell, E. Sanavio, 1999 .

Clozapine treatment of different psychoses

P. Gaszner, 2000, European Neuropsychopharmacology.

The Peripheral Anticholinergic Activity of Tricyclic Antidepressants: Comparison of Amitriptyline and Desipramine in Human Volunteers

C. Bradshaw, E. Szabadi, P. Gaszner, 1980, British Journal of Psychiatry.

Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients.

P. Gaszner, Z. Rónai, A. Guttman, 2002, Current medicinal chemistry.

Treatment possibilities of Alzheimer's disease.

P. Gaszner, I. Miklya, 2004, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

Cross-national transferability of the two-factor model of parental rearing behaviour : A contrast of data from Canada, the Fed. Rep. Germany, Hungary, Japan, Singapore and Venezuela with Dutch target ratings on the EMBU

S. Iwawaki, M. Eisemann, W. Arrindell, 1992 .

Comparison between genes of Alzheimer's disease and brain tissue of others.

P. Gaszner, L. Havas, 2006, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

Prescribing for inpatients with schizophrenia: an international multi-center comparative study.

A. Iwanami, I. Bitter, P. Gaszner, 2003, Pharmacopsychiatry.

About the menopausal depression.

P. Gaszner, 2005, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

Major depression and the synthetic enhancer substances, (−)-deprenyl and R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane

P. Gaszner, I. Miklya, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.

P. Gaszner, I. Miklya, 2004, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

The Use of Planar Electrophoresis for Detection of Single-Nucleotide Polymorphism

P. Gaszner, Z. Rónai, H. Kalasz, 2002, JPC – Journal of Planar Chromatography – Modern TLC.

Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence.

P. Gaszner, A. Székely, Á. Szilágyi, 2005, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

Cross-national generalizability of patterns of parental rearing behaviour: Invariance of EMBU dimensional representations of healthy subjects from Australia, Denmark, Hungary, Italy and The Netherlands

M. Eisemann, W. Arrindell, P. Gaszner, 1986 .

Clinical efficacy of reboxetine: a comparative study with desipramine, with methodological considerations

J. Macher, P. Gaszner, A. Torres-Ruiz, 1998 .

Interaction of desipramine and amitriptyline with adrenergic mechanisms in the human iris in vivo

C. Bradshaw, E. Szabadi, P. Gaszner, 2004, European Journal of Clinical Pharmacology.

Comparison of the effects of desipramine and amitriptyline on pupillary responses to noradrenaline and methoxamine in healthy volunteers [proceedings].

C. Bradshaw, E. Szabadi, P. Gaszner, 1980, British journal of clinical pharmacology.

Agranulocytosis during clozapine therapy

P. Gaszner, Z. Makkos, P. Kosza, 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers

C. Bradshaw, E. Szabadi, P. Gaszner, 2004, Psychopharmacology.

Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder.

P. Gaszner, M. Versiani, L. Mehilane, 1999, The Journal of clinical psychiatry.

Depressive symptomatology at admission in Hungarian and Swedish depressed patients.

M. Eisemann, P. Gaszner, H. Perris, 1987, Psychopathology.

Phobic anxiety in 11 nations. Part I: Dimensional constancy of the five-factor model.

J. Kenardy, R. Edelmann, R. Bentall, 2003, Behaviour research and therapy.

Report on the sixth consensus conference on the methodology of clinical trials with hypnotic drugs.

E. Rüther, A. Borbély, P. Gaszner, 1995, Pharmacopsychiatry.

Comparison of the effects of adrenoceptor and cholinoceptor agonists on sweat gland activity in man.

C. Bradshaw, E. Szabadi, P. Gaszner, 1980, British journal of clinical pharmacology.

Culturally-sensitive complaints of depressions and anxieties in women.

R. Alarcón, H. Calil, P. Gaszner, 2007, Journal of affective disorders.

Clozapine maintenance therapy in schizophrenia

P. Gaszner, Z. Makkos, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Cross-National Generalizability of Dimensions of Perceived Parental Rearing Practices: Hungary and the Netherlands; A Correction and Repetition with Healthy Adolescents

M. Eisemann, P. Gaszner, J. van der Ende, 1989, Psychological reports.